× We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click our cookies policy for information on how to change your cookie settings.


meta|Evidence - COVID-19

Live meta-analysis and evidence synthesis of therapies for COVID19

tutorial video
En     Fr

Our approach
     
Treament Trials
deathsclinical improvementdeath or ventilation
10 -520 [-1633; 594] /10000
85/151 vs. 91/148
NaN [NaN; NaN] /10000
0/0 vs. 0/0
-858 [-2454; 738] /10000
32/76 vs. 37/73
1 110 [-807; 1028] /10000
22/158 vs. 10/78
NaN [NaN; NaN] /10000
0/0 vs. 0/0
-
4 ---
9 -366 [-1050; 318] /10000
33/279 vs. 24/155
879 [-1043; 2800] /10000
27/52 vs. 22/51
-
2 ---
10 -732 [-1181; -282] /10000
165/805 vs. 173/622
242 [-570; 1053] /10000
147/161 vs. 72/81
-179 [-1038; 681] /10000
17/161 vs. 10/81
4 -1355 [-2658; -52] /10000
10/45 vs. 142/397
NaN [NaN; NaN] /10000
0/0 vs. 0/0
-
1 -581 [-1731; 569] /10000
19/99 vs. 25/100
NaN [NaN; NaN] /10000
0/0 vs. 0/0
-
0---
1 167 [-426; 759] /10000
8/120 vs. 6/120
--
0---

Demonstrated: statistically demonstrated that is statistically significant with a strict control of overall risk of type 1 error; inconclusive: not nominally statistically significant; suggested: nominally statistically significant but without a strict control of overall risk of type 1 error

This project is supported by a grant of the French Ministry of Health (Hospital Clinical Research Program, PHRC-N) and self-funded by Hospices Civils de Lyon, CNRS UMR5558 LBBE University Lyon-1.

   

- About - Our approach - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons